LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Brooks McAdam – New CEO of Camber Spine
Company News

Brooks McAdam – New CEO of Camber Spine

November 22, 2023 2 min read Premium comments

Advertisement

Brooks McAdam – New CEO of Camber Spine
Brooks McAdam – New CEO / Courtesy of Camber Spine
Secondary#camberspine#brooksmcadam

On November 16, 2023, King of Prussia, Pennsylvania-based Camber Spine announced that Brooks McAdam, Camber’s chief operating officer would be adding the duties of chief executive officer and board member to his already prodigious plate.

Immediate past CEO Dan Pontecorvo announced the transition in a letter to shareholders, employees, and friends of the company saying, in part, “I am incredibly pleased, and extremely excited to announce the promotion of Brooks McAdam to Chief Executive Officer of Camber Spine.” Pontecorvo will become the Executive Chairman of Camber Spine’s Board of Directors.

Founded in 2011, Camber Spine’s mission was, wrote Pontecorvo, to deliver innovation to spine surgeons “through collaboration with partners at Institute for Musculoskeletal Science and Education (IMSE) and our incredible surgeon faculty.”

“Camber Spine has led the industry with two highly innovative and IP protected device platforms, ENZAÒ MIS Integrated Interbody and SPIRAÒ Open Architecture spinal fusion and orthopedic implants to support faster spinal fusion and recovery. With an incredible portfolio grounded in technology and a growing database of clinicals and scientific evidence we’re excited about the future.”

From Interpore Cross to Medtronic Sofamor Danek, Globus, Then Camber Spine

Brooks entered the spine industry 22 years ago with Anaheim, California-based Interpore Cross International, Inc., where he grew a newly established territory in Hampton Roads, Virginia, to $2.2 million business in just 18 months. Interpore Cross was sold to Biomet in 2004 for about $300 million.

By then, McAdam had been recruited to Memphis-based Medtronic Sofamor Danek where he spent the ensuing several years outpacing quota and building a multi-million-dollar territory.

In 2009, he joined Audubon, Pennsylvania-based Globus Medical, Inc. as a sales territory manager, and spent the next seven years working in the Virginia, Pennsylvania, New Jersey, and Miami markets before joining the Sales Training Department.

Advertisement

As group manager of sales training, Brooks drove a restructuring that elevated the company’s sales training program into one of the best in the industry. In 2017, he worked closely with Globus’s capital sales team to develop a comprehensive sales training program in preparation for the launch of their robotics platform.

According to co-founder Pontecorvo: “Since joining Camber Spine Technologies in 2020, Brooks has established himself as a leader serving in multiple roles and driving efficiency throughout the organization. He has played a critical role in the development and growth of Camber’s OLIF portfolio, restructuring supply chain and finance, as well as leading a growing sales team. Brooks has quickly risen through the ranks as Vice President of Operations and most recently our Chief Operating Officer. Over the last 18 months his work has had a significant impact on Camber’s profitability and culture.”

“Brooks spent his entire career working for two of the biggest players within the orthopedic industry prior to joining Camber Spine, Globus, and Medtronic, Brooks has developed a deep understanding of the spine market.”

“The board and I stand confident in the future of Camber Spine, knowing that it will be in the hands of Brooks, a tenacious, customer centric spine industry expert whose background in fierce award-winning sales development and team building makes him the right leader to take Camber to the next level.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy